Historique
L. AMASS ;
W. LING ;
T. E. FREESE ;
C. REIBER ;
J. J. ANNON ;
A. J. COHEN ;
D. McCARTY ;
M. S. REID ;
L. S. Jr BROWN ;
C. CLARK ;
ZIEDONIS D. M. ;
J. KREJCI ;
STINE S. ;
T. WINHUSEN ;
G. BRIGHAM ;
D. BABCOCK ;
MUIR J. A. ;
B. J. BUCHAN ;
T. HORTON
|
2004
Dans American Journal on Addictions (Vol.13, Suppl.1, May-June 2004) Article : Périodique
Dans American Journal on Addictions (Vol.13, Suppl.1, May-June 2004) Article : Périodique
In October 2002, the US Food and Drug Administration approved buprenorphine-naloxone (Suboxone) sublingual tablets as an opioid dependence treatment available for use outside traditionally licensed opioid treatment programs. The NIDA Center for [...]
